Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

Conditions: Neuromyelitis Optica Spectrum Disorder Interventions: Device: MR-C-014 Sponsors: MedRhythms, Inc.; Alexion Pharmaceuticals, Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06374264

Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

More News: Brain | Neurology | Research